MAPT and type 2 diabetes mellitus: HbA1c in T2D is a surrogate of chronic inflammation due to hyperglycemia [16,17], whereas GFAP and NfL are novel biomarkers of neuroinflammation and axonal injury, respectively, which do not seem to play a major role in amyloid/tau pathology [24].